Read + Share
Amedeo Smart
Independent Medical Education
Iborra M, Caballol B, Garrido A, Huguet JM, et al. Subcutaneous infliximab cut-off points in patients with inflammatory bowel disease. Data from the ENEIDA registry. J Crohns Colitis 2024 Aug 22:jjae127. doi: 10.1093.PMID: 39171615
Email
LinkedIn
Privacy Policy